FRM
Fox Run Management’s Edwards Lifesciences EW Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q4 | – | Sell |
-6,498
| Closed | -$429K | – | 961 |
|
2024
Q3 | $429K | Buy |
+6,498
| New | +$429K | 0.1% | 417 |
|
2024
Q2 | – | Sell |
-12,926
| Closed | -$1.24M | – | 860 |
|
2024
Q1 | $1.24M | Buy |
+12,926
| New | +$1.24M | 0.27% | 75 |
|
2023
Q4 | – | Sell |
-9,990
| Closed | -$692K | – | 809 |
|
2023
Q3 | $692K | Buy |
+9,990
| New | +$692K | 0.2% | 162 |
|
2023
Q2 | – | Sell |
-5,680
| Closed | -$470K | – | 766 |
|
2023
Q1 | $470K | Sell |
5,680
-2,077
| -27% | -$172K | 0.15% | 239 |
|
2022
Q4 | $579K | Buy |
7,757
+1,355
| +21% | +$101K | 0.23% | 126 |
|
2022
Q3 | $529K | Buy |
+6,402
| New | +$529K | 0.21% | 159 |
|
2022
Q2 | – | Sell |
-2,586
| Closed | -$304K | – | 594 |
|
2022
Q1 | $304K | Buy |
+2,586
| New | +$304K | 0.17% | 270 |
|
2021
Q3 | – | Sell |
-3,108
| Closed | -$322K | – | 513 |
|
2021
Q2 | $322K | Buy |
+3,108
| New | +$322K | 0.29% | 146 |
|
2020
Q1 | – | Sell |
-1,625
| Closed | -$379K | – | 193 |
|
2019
Q4 | $379K | Buy |
+1,625
| New | +$379K | 0.31% | 108 |
|
2019
Q1 | – | Sell |
-4,677
| Closed | -$716K | – | 532 |
|
2018
Q4 | $716K | Buy |
4,677
+2,953
| +171% | +$452K | 0.38% | 34 |
|
2018
Q3 | $300K | Sell |
1,724
-2,315
| -57% | -$403K | 0.13% | 345 |
|
2018
Q2 | $588K | Buy |
+4,039
| New | +$588K | 0.19% | 175 |
|
2017
Q4 | – | Sell |
-13,400
| Closed | -$1.47M | – | 733 |
|
2017
Q3 | $1.47M | Buy |
13,400
+9,300
| +227% | +$1.02M | 0.41% | 10 |
|
2017
Q2 | $485K | Sell |
4,100
-10,600
| -72% | -$1.25M | 0.17% | 229 |
|
2017
Q1 | $1.38M | Buy |
+14,700
| New | +$1.38M | 0.56% | 2 |
|
2016
Q3 | – | Sell |
-6,600
| Closed | -$658K | – | 547 |
|
2016
Q2 | $658K | Sell |
6,600
-400
| -6% | -$39.9K | 0.32% | 59 |
|
2016
Q1 | $617K | Sell |
7,000
-2,800
| -29% | -$247K | 0.41% | 42 |
|
2015
Q4 | $774K | Buy |
+9,800
| New | +$774K | 0.6% | 10 |
|